IMRN

Immuron Limited American Depositary Shares (IMRN)

About Immuron Limited American Depositary Shares (IMRN)

Immuron Ltd. is a biopharmaceutical company, which focuses on the development and commercialization of a novel class of specifically targeted polyclonal antibodies. Its proprietary technology is based on polyclonal immunoglobulins derived from engineered hyper-immune bovine colostrum. This technology can be used to target viruses or bacteria and neutralize the toxins they produce on mucosal surfaces. It operates through the Research and Development, and Hyperimmune Products segments. The Research and Development segment includes projects performed in Australia and United States. The Hyperimmune Products segment is composed of Travelan, and Protectyn activities which occur in Australia, United States, and rest of the world. The company was founded on January 13, 1994, and is headquartered in Carlton, Australia.

Details

Daily high
$2.25
Daily low
$2.05
Price at open
$2.27
52 Week High
$5.96
52 Week Low
$1.48
Market cap
12.6M
Dividend yield
0.00%
Volume
9,029
Avg. volume
7,173
P/E ratio
-2.75

Immuron Limited American Depositary Shares News

Details

Daily high
$2.25
Daily low
$2.05
Price at open
$2.27
52 Week High
$5.96
52 Week Low
$1.48
Market cap
12.6M
Dividend yield
0.00%
Volume
9,029
Avg. volume
7,173
P/E ratio
-2.75